Holmøy T - Search Results

1

High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.

Holmøy T, Lindstrøm JC, Eriksen EF, Steffensen LH, Kampman MT. Holmøy T, et al. BMC Neurol. 2017 Apr 4;17(1):67. doi: 10.1186/s12883-017-0851-0. BMC Neurol. 2017. PMID: 28376767 Free PMC article. Clinical Trial.

2

Infectious causes of multiple sclerosis.

Holmøy T, Vartdal F. Holmøy T, et al. Lancet Neurol. 2005 May;4(5):268; discussion 269. doi: 10.1016/S1474-4422(05)70054-5. Lancet Neurol. 2005. PMID: 15847838 No abstract available.

3

Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway.

Smestad C, Sandvik L, Holmoy T, Harbo HF, Celius EG. Smestad C, et al. Among authors: holmoy t. J Neurol. 2008 Jan;255(1):49-55. doi: 10.1007/s00415-007-0659-8. Epub 2007 Dec 20. J Neurol. 2008. PMID: 18080855

4

Environmental risk factors in multiple sclerosis.

Pugliatti M, Harbo HF, Holmøy T, Kampman MT, Myhr KM, Riise T, Wolfson C. Pugliatti M, et al. Among authors: holmoy t. Acta Neurol Scand Suppl. 2008;188:34-40. doi: 10.1111/j.1600-0404.2008.01029.x. Acta Neurol Scand Suppl. 2008. PMID: 18439219 Review.

5

25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis.

Holmøy T, Moen SM, Gundersen TA, Holick MF, Fainardi E, Castellazzi M, Casetta I. Holmøy T, et al. Mult Scler. 2009 Nov;15(11):1280-5. doi: 10.1177/1352458509107008. Epub 2009 Oct 6. Mult Scler. 2009. PMID: 19808741

6

Alaska, multiple sclerosis, and the vitamin D hypothesis.

Holmøy T, Kampman MT. Holmøy T, et al. J Neurol. 2010 Feb;257(2):305-6. doi: 10.1007/s00415-009-5360-7. Epub 2009 Oct 28. J Neurol. 2010. PMID: 19862468 No abstract available.

7

[Development of new therapies for multiple sclerosis].

Holmøy T, Celius EG. Holmøy T, et al. Tidsskr Nor Laegeforen. 2011 May 6;131(8):832-6. doi: 10.4045/tidsskr.10.0077. Tidsskr Nor Laegeforen. 2011. PMID: 21556088 Free article. Review. Norwegian.

8

Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications?

Kampman MT, Eriksen EF, Holmøy T. Kampman MT, et al. Among authors: holmoy t. Acta Neurol Scand Suppl. 2011;(191):44-9. doi: 10.1111/j.1600-0404.2011.01543.x. Acta Neurol Scand Suppl. 2011. PMID: 21711256 Review.

9

Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome.

Moen SM, Celius EG, Sandvik L, Nordsletten L, Eriksen EF, Holmøy T. Moen SM, et al. Among authors: holmoy t. Neurology. 2011 Jul 12;77(2):151-7. doi: 10.1212/WNL.0b013e3182242d34. Neurology. 2011. PMID: 21747073

10

Intrathecal levels of vitamin D and IgG in multiple sclerosis.

Holmøy T, Lossius A, Gundersen TE, Moen SM, Castellazzi M, Fainardi E, Casetta I. Holmøy T, et al. Acta Neurol Scand. 2012 Jun;125(6):e28-31. doi: 10.1111/j.1600-0404.2011.01577.x. Epub 2011 Jul 23. Acta Neurol Scand. 2012. PMID: 21781056

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

205 results

Search Page